Skip to main content

What are the indications of pirenzepine?

  • Conference paper
Benign Lesions of the Esophagus and Cancer
  • 16 Accesses

Abstract

At the parietal gastric cells where hydrochloric acid is secreted there are cholinergic receptors, particularly muscarinic receptors. Pirenzepine is a pyridobenzodiazepine which blocks the Ml muscarinic receptors of the gastric wall exerting a selective anti- muscarinic action. This produces an inhibition of acid gastric secretion which is greater and more prolonged than with traditional anticholinergics. It is this action against acid secretion that has led to pirenzepine being proposed for the treatment of gastroesophageal reflux as it combats the noxious effect of the acidity of the reflux fluid.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cecconello I, Zilberstein B, Pinotti M, Pollara WM, Pugliese V, Nasi A, Pinotti HW (1986) Treatment of reflux œsophagitis with pirenzepin. Symposium 8ème Congrès Mondial de Gastroentérologie. Sao Paulo

    Google Scholar 

  2. Denis P, Galmiche JP, Gibon JF, Colin R, Pasquis P, Lefrancois R (1982) Effet du pirenzepin sur la motricité œsophagienne chez l’aduhe sain. Gastroenterol Clin Biol 6: 27–31

    PubMed  CAS  Google Scholar 

  3. Evreux M, Jacquet N (1984) La pirenzepine dans le traitement de l’œsophagite. Rev Fr Gastroenterol 20 (204): 18–21

    Google Scholar 

  4. Gouerou H (1986) Etude multicentrique pirenzepine versus cimetidine dans le traitement du reflux gastro-œsophagien. Rapport d’expertise clinique

    Google Scholar 

  5. Kohek PH, Rehak PH, Friehs GB (1984) Effet de la pirenzepine sur le sphincter inférieur de l’œsophage. Medwelt 35: 943–945

    Google Scholar 

  6. Minaire Y (1985) Etude de l’effet de la pirenzepine chez des patients porteurs d’une hypotonie du sphincter inférieur de l’œsophage. Rapport de pharmacologie clinique

    Google Scholar 

  7. Niemela S, Lehtola J, Krekela I, Jaaskelainen T, Martikamen J, Sarna S, Sarelin H (1986) Pirenzepin in the treatment of reflux œsophagitis: a placebo-controlled double-bhnd study. Symposium. 8ème Congrès Mondial de Gastroentérologie. Sao Paulo

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Maffioli, C. (1989). What are the indications of pirenzepine?. In: Giuli, R., McCallum, R.W. (eds) Benign Lesions of the Esophagus and Cancer. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73055-9_77

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73055-9_77

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-73057-3

  • Online ISBN: 978-3-642-73055-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics